Microcap Ledger

Tickers · $MTEX

Mannatech Inc $MTEX

By Microcap Ledger desk · CIK 0001056358

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Medicinal Chemicals & Botanical Products
Headquarters
Flower Mound, TX
Fiscal year end
December 31
Shares outstanding
1,929,670 [10-Q 2026-08-12]
as of 2026-08-05

Sources: [10-K 2026-04-15]

What the company doesAI summary of filing

Mannatech, Incorporated develops and sells nutritional supplements, skin care products, and weight-management products. The company distributes its products primarily through network marketing channels via independent associates and preferred customers in markets across the Americas, Europe, the Middle East, Africa, and Asia-Pacific, as well as through a cross-border e-commerce subsidiary in China. The company is revenue-generating, with approximately 114,000 active associate and preferred customer positions as of December 31, 2025. Mannatech makes money through commissions and incentives paid to independent associates based on product sales, with commission rates ranging from 35 to 43 percent of consolidated net sales. [10-K 2026-04-15]

Segments: Integrative Health, Targeted Health, Weight and Fitness, Skin Care

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$51.57M$1.97M $334.0K$6.03M[10-Q 2026-08-12]
FY ended Dec 2025$108.04M−$15.20M −$2.96M$6.18M[10-K 2026-04-15]
FY ended Dec 2024$117.87M$2.50M $2.26M$11.40M[10-K 2026-04-15]

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-07-311,884,814[10-Q 2024-08-13]
2024-10-311,884,814[10-Q 2024-11-12]
2025-03-181,900,930[10-K 2025-03-26]
2025-05-061,900,930[10-Q 2025-05-13]
2025-11-041,900,930[10-Q 2025-11-12]
2026-04-081,929,670[10-K 2026-04-15]
2026-05-051,929,670[10-Q 2026-05-14]
2026-08-051,929,670[10-Q 2026-08-12]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-04-24. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-04-248-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-04-24]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-05-20Jobe Larry Abuy2,803$4.12[4 2026-05-21]
2026-05-19Jobe Larry Abuy5,000$4.20[4 2026-05-20]
2026-05-19Robbins Kevin Andrewbuy7,100$4.17[4 2026-05-20]
2026-01-02Jobe Larry Agrant4,790$8.35[4 2026-01-06]
2026-01-02Robbins Kevin Andrewgrant4,790$8.35[4 2026-01-06]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-09-018-KDirector or officer change
2026-08-1913G/ABeneficial ownership report (5%+ holder)
2026-08-1913G/ABeneficial ownership report (5%+ holder)
2026-08-128-KResults of operations
2026-08-1210-QQuarterly report
2026-06-088-KDirector or officer change
2026-06-038-KShareholder vote results
2026-05-148-KResults of operations
2026-05-1410-QQuarterly report
2026-04-248-KListing notice or transfer
2026-04-2413DBeneficial ownership report (5%+ holder)
2026-04-21DEF 14AProxy statement

Facts as of . Small caps move fast; check the latest filings.